Predictors of treatment response in adolescent depression

Psychiatric Annals

Volumn 41, Issue 4, 2011, Pages 212-219

  Emslie, Graham J ^a   Kennard, Betsy D ^b   Mayes, Taryn L ^b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79959235753     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/00485713-20110325-04     Document Type: Article

References (19)

1. Birmaher B, Brent DA, AACAP Work Group on Quality Issues, et al. Practice Parameter for the Assessment and Treatment of Children and Adolescents with Depressive Disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(11):1503-1526.
2. Emslie GJ, Mayes T, Porta G, et al. Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes. Am J Psychiatry. 2010;167(7):782-791.
3. Emslie GJ, Kennard BD, Mayes TL, et al. Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. Am J Psychiatry. 2008;165(4):459-467.
4. Tao R, Emslie G, Mayes T, Nakonezny P, Kennard B, Hughes C. Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder. J Am Acad Child Adolesc Psychiatry. 2009;48(1):71-78.
5. March J, Silva S, Petrycki S, et al; Treatment for Adolescents With Depression Study (TADS) Team. Fluoxetine, Cognitive-Behavioral Therapy, and Their Combination for Adolescents with Depression Treatment for Adolescents with Depression Study (TADS): randomized controlled trial. JAMA. 2004;292(7):807-820.
6. Brent D, Emslie G, Clarke G, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. 2008;299(8):901-913.
7. Goodyer IM, Dubicka B, Wilkinson P, et al. Selective Serotonin Reuptake Inhibitors (SSRIs) and Routine Specialists Care with and without Cognitive Behavior Therapy in Adolescents with Major Depression: randomised controlled trial. BMJ. 2007;335(7611):142.
8. TADS Team. The Treatment for Adolescents with Depression Study (TADS): demographic and clinical vharacteristics. J Am Acad Child Adolesc Psychiatry. 2005;44(1):28-40.
9. Kennard BD, Silva SG, Tonev S, et al. Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and longterm outcomes. J Am Acad Child Adolesc Psychiatry. 2009;48(2):186-195.
10. Curry JF, Rohde P, Simons AD, et al. Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry. 2006;45(12):1427-1439.
11. Asarnow JR, Emslie G, Clarke G, et al. Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response. J Am Acad Child Adolesc Psychiatry. 2009;48(3):330-339.
12. Curry J, Silva S, Rohde P, Ginsburg G, et al. Recovery and recurrence following Treatment for Adolescent Major Depression. Arch Gen Psychiatry. 2011;68(3):263-269.
13. Wilkinson P, Dubicka B, Kelvin R, Roberts C, Goodyer I. Treated depression in adolescents: predictors of outcome at 28 weeks. Br J Psychiatry. 2009;194(4):334-341.
14. Emslie GJ, Kratochvil C, Vitiello B, et al. Treatment for Adolescents with Depression Study (TADS): safety results. J Am Acad Child Adolesc Psychiatry. 2006;45(12):1440-1455.
15. Vitiello B. Combined cognitive-behavioural therapy and pharmacotherapy for adolescent depression: does it improve outcomes compared with monotherapy? CNS Drugs. 2009;23(4):271-280.
16. Kratochvil CJ, May DE, Silva SG, et al. Treatment response in depressed adolescents with and without co-morbid attention-deficit/hyperactivity disorder in the Treatment for Adolescents with Depression Study. J Child Adolesc Psychopharmacol. 2009;19(5):519-527.
17. Feeny NC, Silva SG, Reinecke MA, et al. An exploratory analysis of the impact of family functioning on treatment for depression in adolescents. J Clin Child Adolesc Psychol. 2009;38(6):814-825.
18. Lewis CC, Simons AD, Nguyen LJ, et al. Impact of childhood trauma on treatment outcome in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry. 2010;49(2):132-140.
19. Fava GA, Fabbri S, Sonino N. Residual symptoms in depression: an emerging therapeutic target. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26(6):1019-1027.